1991
DOI: 10.1016/0378-1119(91)90039-e
|View full text |Cite
|
Sign up to set email alerts
|

Tn5-rpsL: a new derivative of transposon Tn5 useful in plasmid curing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

1994
1994
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 23 publications
0
7
0
Order By: Relevance
“…An elegant solution is to use a transposon carrying a counterselectable marker. Tn5-derived mini-transposons, containing rpsL or sacB, were used to cure plasmids from Salmonella (51) and Rhizobium (18) strains in two-step selection protocols. First, a mutant in which the mini-transposon has integrated into the plasmid to be cured is selected either by DNA-DNA hybridization with the mini-transposon as a probe or by exconjugation.…”
Section: Selection Of Plasmid Alterationsmentioning
confidence: 99%
“…An elegant solution is to use a transposon carrying a counterselectable marker. Tn5-derived mini-transposons, containing rpsL or sacB, were used to cure plasmids from Salmonella (51) and Rhizobium (18) strains in two-step selection protocols. First, a mutant in which the mini-transposon has integrated into the plasmid to be cured is selected either by DNA-DNA hybridization with the mini-transposon as a probe or by exconjugation.…”
Section: Selection Of Plasmid Alterationsmentioning
confidence: 99%
“…Selectable markers are used for plasmid maintenance, engineered conjugation and genome manipulations (1). In contrast, counter-selectable markers such as sacB (2) or barnase (3) are useful tools for different applications, such as plasmid curing (4,5), scar-less gene deletion (2) or engineering double-crossovers (6). However, counter-selectable markers often require stringent growth conditions to achieve robust counter-selection performance, and there are few means to ensure proper function of counter-selectable markers in vivo , which limit their application.…”
Section: Introductionmentioning
confidence: 99%
“…One marker allowing the required negative selection is based on a common spontaneous bacterial streptomycin (Sm) resistance mutation in the gene rpsL that causes a lysine replacement in protein S12 of the small ribosomal subunit (21). As this mutation is recessive, an rpsL ϩ allele has been employed to provide a dominant drug-sensitive phenotype in genetic contexts where it can provide direct selection for deletion, mutation, or replacement events (5,7,8,17,20,(22)(23)(24)(25). Here we describe application of this principle for construction of an rpsL cassette for use in S. pneumoniae that allows use of antibiotics at both selection steps and show that it can be used with natural genetic transformation for gene replacement through negative selection.…”
mentioning
confidence: 99%